/Investor DB

Westlake Village BioPartners — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Kyverna Therapeuticskyvernatx.cominNASDAQ: KYTXSeries A · Jan 2020 · $25M

Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.

BiotechEmeryville, US

Warner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)Peter Maag(Executive Officer, Director)in

Co-investorsBain Capital Life SciencesVida VenturesGilead SciencesInsight PartnersKleiner PerkinsNorthpond Ventures+3 more

Acelyrinacelyrin.comin𝕏Series A · Dec 2020 · $8Macquired by Alumis

AI & Machine LearningBiotechDigital HealthHealthtech

Co-investorsDecheng CapitalSamsara BioCapitalvenBio PartnersAccess IndustriesKleiner Perkins

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.